{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:30:08Z","timestamp":1777721408002,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.biomaterials.2011.04.043","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T23:42:55Z","timestamp":1306194175000},"page":"5643-5662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sustained targeting of Bcr\u2013Abl\u00a0+\u00a0leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy"],"prefix":"10.1016","volume":"32","author":[{"given":"Sarbari","family":"Acharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeeb K.","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2011.04.043_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.cdd.4400213","article-title":"Downregulation of Bcr-Abl in K562 cells restores susceptibility to apoptosis: characterization of the apoptotic death","volume":"4","author":"McGahon","year":"1997","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib2","first-page":"607","article-title":"The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr\/c-abl transcript","volume":"6","author":"Grosveld","year":"1986","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib4","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/sj.onc.1201400","article-title":"The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells","volume":"15","author":"Cortez","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib5","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib6","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1038\/sj.onc.1206082","article-title":"BCR\/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia","volume":"21","author":"Salesse","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"Eng Med"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib8","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1182\/blood-2003-12-4121","article-title":"Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr\/Abl-dependent and -independent mechanisms","volume":"104","author":"Dai","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V99.2.664","article-title":"Effects of the Bcr\/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in\u00a0vitro","volume":"99","author":"Mow","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"Lehar","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib12","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/sj.onc.1209968","article-title":"Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice","volume":"26","author":"Perez-Caro","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib13","first-page":"8420","article-title":"Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells","volume":"63","author":"Rahmani","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib14","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2003-03-0737","article-title":"The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr\/Abl+ cells sensitive and resistant to STI571","volume":"102","author":"Yu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2008.08.021","article-title":"STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis","volume":"596","author":"Jakubowska","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1182\/blood-2005-06-2318","article-title":"Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia","volume":"107","author":"Du","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/10611860701794353","article-title":"Polymeric nanoparticles for cancer therapy","volume":"16","author":"Parveen","year":"2008","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib18","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","article-title":"Nanotech approaches to drug delivery and imaging","volume":"8","author":"Sahoo","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib19","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1016\/j.biomaterials.2009.07.008","article-title":"Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy","volume":"30","author":"Acharya","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2009.11.010","article-title":"Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy","volume":"39","author":"Misra","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/mp050032z","article-title":"Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention","volume":"2","author":"Sahoo","year":"2005","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.actbio.2010.08.010","article-title":"Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy","volume":"7","author":"Das","year":"2010","journal-title":"Acta Biomater"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/nnm.10.9","article-title":"Curcumin-encapsulated MePEG\/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy","volume":"5","author":"Mohanty","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2009.01.018","article-title":"Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles","volume":"135","author":"Nam","year":"2009","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1023\/A:1022219003551","article-title":"Dynamics of endocytosis and exocytosis of poly(D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells","volume":"20","author":"Panyam","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib26","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.actbio.2010.02.010","article-title":"Enhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell line","volume":"6","author":"Parveen","year":"2010","journal-title":"Acta Biomater"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib27","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1016\/j.biomaterials.2010.08.010","article-title":"Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer","volume":"31","author":"Vandana","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(02)00315-0","article-title":"Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles","volume":"244","author":"Prabha","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.drudis.2010.08.006","article-title":"Cancer nanotechnology: application of nanotechnology in cancer therapy","volume":"15","author":"Misra","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2009","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib31","doi-asserted-by":"crossref","DOI":"10.1021\/am101196v","article-title":"Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and Hydrophilic anticancer drugs and MRI imaging for cancer therapy","author":"Singh","year":"2011","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2005.01.010","article-title":"Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention","volume":"104","author":"Zhigaltsev","year":"2005","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-3659(02)00352-8","article-title":"Cytoplasmic delivery and nuclear targeting of synthetic macromolecules","volume":"87","author":"Jensen","year":"2003","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2006.09.014","article-title":"Uptake and metabolism of novel biodegradable poly (glycerol-adipate) nanoparticles in DAOY monolayer","volume":"116","author":"Meng","year":"2006","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery","volume":"16","author":"Panyam","year":"2002","journal-title":"Faseb J"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.devcel.2005.03.013","article-title":"Cell-cycle control during development: taking it up a notch","volume":"8","author":"Tomas","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/74994","article-title":"Mitochondrial control of cell death","volume":"6","author":"Kroemer","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0092-8674(00)80564-4","article-title":"Cell death in development","volume":"96","author":"Vaux","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1006\/bbrc.1997.6353","article-title":"Release of cytochrome c from liver mitochondria during permeability transition","volume":"232","author":"Kantrow","year":"1997","journal-title":"Biochem Biophys Re Commun"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0962-8924(00)01803-1","article-title":"Mitochondria as the central control point of apoptosis","volume":"10","author":"Desagher","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2009.41.1.1","article-title":"Advances of cancer therapy by nanotechnology","volume":"41","author":"Wang","year":"2009","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib43","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1016\/j.biomaterials.2010.01.057","article-title":"Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy","volume":"31","author":"Dilnawaz","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-3659(01)00549-1","article-title":"Torres Suarez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers\u2013liposomes and microspheres\u2013on the phagocytosis by macrophages","volume":"79","author":"Ahsan","year":"2002","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib45","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-07-0397","article-title":"Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells","volume":"7","author":"Hui","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/nnm.10.8","article-title":"Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL+ leukemia stem cells","volume":"5","author":"Palama","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.biopha.2009.09.002","article-title":"Antitumor effect of N-succinyl-chitosan nanoparticles on K562 cells","volume":"64","author":"Luo","year":"2009","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/mp800149s","article-title":"Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2","volume":"6","author":"Yang","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib49","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0145-2126(98)00092-7","article-title":"Divergent effect of taxol on proliferation, apoptosis and nitric-oxide production in MHH225 CD34-positive and U937 CD34-negative human leukemia cells","volume":"22","author":"Al Alami","year":"1998","journal-title":"Leuk Res"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib50","first-page":"229","article-title":"Bcl2 is the guardian of microtubule integrity","volume":"57","author":"Haldar","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<527::AID-IJC14>3.0.CO;2-#","article-title":"Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation","volume":"85","author":"Gangemi","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib52","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1016\/j.biomaterials.2008.07.004","article-title":"Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging","volume":"29","author":"Jain","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib53","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1172\/JCI9054","article-title":"Anticancer drug targets: cell cycle and checkpoint control","volume":"104","author":"Shapiro","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib54","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1073\/pnas.90.20.9552","article-title":"Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations","volume":"90","author":"Jordan","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib55","first-page":"1041","article-title":"Activation of p34cdc2 coincident with taxol-induced apoptosis","volume":"5","author":"Donaldson","year":"1994","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib56","first-page":"141","article-title":"Synergistic interaction of lovastatin and paclitaxel in human cancer cells","volume":"1","author":"Holstein","year":"2001","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0962-8924(01)02173-0","article-title":"Programmed cell death: alive and well in the new millennium","volume":"11","author":"Kaufmann","year":"2001","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib58","first-page":"333","article-title":"Multidrug resistance in leukemic cell line K562\/A02 induced by doxorubicin","volume":"16","author":"Yang","year":"1995","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib59","first-page":"225","article-title":"Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model","volume":"31","author":"Merimsky","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib60","first-page":"1087","article-title":"Inhibition of phosphatidylinositol 3\u2019-kinase increases efficacy of paclitaxel in in\u00a0vitro and in\u00a0vivo ovarian cancer models","volume":"62","author":"Hu","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib61","first-page":"407","article-title":"Overexpression of Akt\/AKT can modulate chemotherapy-induced apoptosis","volume":"20","author":"Page","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib62","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1158\/1535-7163.MCT-04-0137","article-title":"Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1\/MEK\/ERK, Akt, and JNK signal transduction pathways","volume":"4","author":"Hahn","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib63","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/sj.onc.1207520","article-title":"Prospective strategies to enforce selectively cell death in cancer cells","volume":"23","author":"Blagosklonny","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib64","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis","volume":"94","author":"Li","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/IJN.S7932","article-title":"Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells","volume":"4","author":"Chen","year":"2009","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib67","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.cdd.4400598","article-title":"Caspase structure, proteolytic substrates, and function during apoptotic cell death","volume":"6","author":"Nicholson","year":"1999","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.biomaterials.2011.04.043_bib68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jcp.10254","article-title":"Cell death regulation by the Bcl-2 protein family in the mitochondria","volume":"195","author":"Tsujimoto","year":"2003","journal-title":"J\u00a0Cell Physiol"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211004509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211004509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:29:44Z","timestamp":1758900584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961211004509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":68,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0142961211004509"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.04.043","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained targeting of Bcr\u2013Abl\u00a0+\u00a0leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}